Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |